• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
LongeCity .                       Advocacy & Research for Unlimited Lifespans

Photo
- - - - -

Resveratrol as companion with blood pressure medicines

resveratrol blood pressure hypertension

  • Please log in to reply
No replies to this topic

#1 bluemoon

  • Registered User
  • 389 posts
  • 19
  • Location:south side
  • NO

Posted 02 March 2017 - 03:00 PM


 
(Oops. I missed that this was already posted)
 
From Resveratrol News, February 1, 2017:
 
"Just 50 milligrams of resveratrol used as a companion with lisinopril (ACE inhibitor) meaningfully increases the effectiveness of anti-hypertension therapy."
 
 
Exp Ther Med. 2017 Jan;13(1):295-301. doi: 10.3892/etm.2016.3958. Epub 2016 Dec 6.
The effect of resveratrol on hypertension: A clinical trial.
Abstract

 

The aim of this clinical trial was to investigate the effects of Evelor, a micronized formulation of resveratrol (RESV; 3,5,4'-trihydroxy-trans-stilbene), in patients with primary hypertension. RESV is a stilbenoid and phytoalexin produced by several plants in response to injury or attack by pathogens, such as bacteria and fungi. Patients included in the clinical trial were split into the following two groups, based on the severity of their disease: Group A (n=46), stage I hypertension [systolic blood pressure (SBP), 140-159 mmHg; diastolic blood pressure (DBP), 90-99 mmHg] and Group B (n=51), stage II hypertension (SBP, 160-179 mmHg; DBP, 100-109 mmHg). Each group was divided into two subgroups: A1 and B1, patients treated with standard antihypertensive therapy (A1, 10 mg Dapril; B1, 20 mg Dapril), and A2 and B2, patients treated with antihypertensive therapy (Dapril) plus Evelor. The present study aimed to determine the effects of Evelor, in addition to the standard hypertension treatment, and its effect on the hepatic enzymes serum glutamate-pyruvate transaminase (SGPT) and gamma-glutamyl transferase (gamma-GT).

 

Following the trial, which lasted two years (October 2010 to October 2012), the mean blood pressure of both groups lay within the normal range, indicating that blood pressure was efficiently controlled. The results of the present study demonstrate that the addition of RESV to standard antihypertensive therapy is sufficient to reduce blood pressure to normal levels, without the need for additional antihypertensive drugs. In addition, statistical analysis of the results identified a significant reduction in plasma concentration levels of SGPT (P<0.001) and gamma-GT (P<0.001) with the addition of RESV, indicating that RESV prevents liver damage.

 

Edited by bluemoon, 02 March 2017 - 03:11 PM.






Also tagged with one or more of these keywords: resveratrol, blood pressure, hypertension

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users